Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2003 December;55(6) > Minerva Pediatrica 2003 December;55(6):625-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532


eTOC

 

CLINICAL CASE  


Minerva Pediatrica 2003 December;55(6):625-8

language: English

Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy

Yalaz M., Aydogdu S., Ozgenc F., Akisu M., Kultursay N., Yagci R. V.


PDF  


Normal fertility is sustained by progress in the medical therapy of Wilson's disease; however, pregnancy complications are encountered more frequently. The mother we present is a Wilson's disease patient who had been compliant with D-penicillamine for the preceding 13 years. She was admitted with unplanned pregnancy at the 16th gestational week. The dose of D-penicillamine could be reduced to 600 mg/d related to the underlying disease. Pregnancy ended with premature labor and delivery at the 29-30th weeks. The baby experienced type I respiratory distress and was treated by surfactant and mechanical ventilation. Neutropenia and leucopenia were documented at 6th postnatal hours. The baby showed neutropenia and leucopenia for 5 days and resolving without any further therapy. Intrauterine D-penicillamine was suspected to cause transient neonatal myelosuppression.

top of page

Publication History

Cite this article as

Corresponding author e-mail